Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Learn how to plan for success using zero based budgeting to achieve your financial goals. Start your journey to success today.
19,670 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Investors are watching a pivotal Starship test as markets gauge the odds of a SpaceX IPO. A successful launch could s...
Analysts weigh whether Credo can reach $350 by 2028 as AI infrastructure spending stays strong and the company accele...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
A proposed federal 401(k) match faces a reality gap: while it aims to help workers without employer plans, millions a...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Private-market real estate opens access to 25,000+ multifamily units as rents rise in low-supply markets, underscorin...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
SpaceX kicked off its long-awaited IPO with shares trading above $150 and a valuation topping $2 trillion. This repor...